CELU · Celularity Inc
United States · RS rating 77 · As of 2026-10-14
| Price | 1.31 USD |
|---|---|
| 1-day change | -7.8% |
| RS rating (overall / 1M / 3M / 12M) | 77 / 90 / 97 / 19 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 24 / 27 / 34 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +13.7% |
| Sales growth Q/Q | -7.9% |
| Distance from 52-week high | +42.3% |
| Market cap (USD) | $32.3M |